We have recently shown that the responsiveness of rat intestinal arterioles to increased sympathetic nerve activity is modulated by the actions of endothelial-derived nitric oxide. Because the microvascular endothelium can also produce vasodilator prostaglandins, the purpose of this study was to determine if endogenous cyclooxygenase products also limit sympathetic arteriolar constriction in this vascular bed. Intravital microscopy was used to study the responses of small feed arteries, first-order arterioles and second-order arterioles to perivascular sympathetic nerve stimulation in the superfused rat small intestine. Stimulation at 3, 8 and 16 Hz caused frequency-dependent constrictions of each vessel type that are abolished by the α-adrenoceptor antagonist phentolamine (10-6M superfusate concentration). The cyclooxygenase inhibitor meclofenamate (3 × 10-5M superfusate concentration) completely abolished the dilator responses to topically applied arachidonic acid, but had no effect on the magnitude or rate of sympathetic constriction in any vessel type. These results suggest that endogenous cyclooxygenase activity does not influence sympathetic tone in the intestinal microvasculature.

Keywords:
Microcirculation, Sympathetic nervous system, Cyclooxygenase products, Endothelium
This content is only available via PDF.
© 1997 S. Karger AG, Basel
1997
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.